Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Molecular biology of lung cancer-a review
Dinesh Pendharkar1, B V Ausekar2, Sumant Gupta3
1Asian Institute of Oncology, S. L. Raheja Hospital, Mahim, Mumbai, 400016 India.
Abstract:
Lung cancer is leading site of cancer in Indian males today. The incidence is on the rise. It is generally diagnosed in late stages. The progression free survival and overall survival still remains low. Majority of oncology research today is driven towards molecular profiling of lung cancer. Receptor tyrosine kinases have emerged as major molecular markers and targets. These are the results of gene mutations or amplifications. There are many developed targets where therapeutic option is available like EGFR, ALK, MET, KRAS and so on. This review features on few important molecular profiles of lung cancer, especially with more therapeutic implications.
Insights
Lung cancer incidence is rising in Indian males, often diagnosed late. This review focuses on key molecular targets, like receptor tyrosine kinases, with therapeutic implications for improved lung cancer survival.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading and increasing cancer in Indian males.
- Diagnosis often occurs at late stages, leading to poor survival rates.
- Current research emphasizes molecular profiling for targeted therapies.
Purpose of the Study:
- To review important molecular profiles of lung cancer.
- To highlight receptor tyrosine kinases as key molecular markers and therapeutic targets.
- To discuss molecular alterations driving lung cancer with therapeutic implications.
Main Methods:
- Literature review of current oncology research.
- Focus on molecular profiling and receptor tyrosine kinases.
- Analysis of gene mutations and amplifications in lung cancer.
Main Results:
- Receptor tyrosine kinases (RTKs) are significant molecular targets in lung cancer.
- Mutations and amplifications in RTKs are common.
- Therapeutic options are available for targets like EGFR, ALK, MET, and KRAS.
Conclusions:
- Molecular profiling is crucial for understanding and treating lung cancer.
- Targeted therapies based on molecular alterations offer improved treatment strategies.
- Further research into molecular profiles can enhance patient survival in lung cancer.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
PI3K/mTOR/AKT Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...

